SCHEMBL6790862

SCHEMBL6790862

CCOC(=O)C1(CSc2ccc(Oc3ccccc3)cc2)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 3/20 0.42
MAPK1 P28482 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 3/20 0.41
EGLN2 Q96KS0 1/20 0.40
USP2 O75604 1/20 0.40
ALOX15 P16050 1/20 0.40
P4HB P07237 1/20 0.40
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6785770 0.91 POLB (0.38) ALDH1A1MAPTLMNAMAPK1GAA
SCHEMBL6268027 0.83 MMP13 (0.56) MEN1KMT2A
SCHEMBL6784917 0.82 MMP13 (0.54) MAPTLMNAMAPK1SMN1; SMN2TSHR
SCHEMBL7302297 0.81 MEN1 (0.44) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL16324661 0.79 MAPK1 (0.65) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL965515 0.78 LMNA (0.62) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL23268322 0.78 MEN1 (0.43) ALDH1A1MEN1KMT2ASMN1; SMN2USP2
SCHEMBL20493167 0.77 MEN1 (0.67) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL6191395 0.77 NR1H2 (0.46)
SCHEMBL1447994 0.76 TACR1 (0.55) ALDH1A1MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds G.D. SEARLE & CO. 2004-05-20 US disclosed
US-6638952-B1 Matrix metalloprotease inhibitors PHARMACIA CORPORATION 2003-10-28 US disclosed
EP-0983257-A4 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS MONSANTO CO (US) 2001-05-02 EP disclosed
EP-0983257-A1 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS Monsanto Company (US) 2000-03-08 EP disclosed
WO-1998039315-A1 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS MONSANTO COMPANY (US) 1998-09-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds MMP1, MMP2, MMP10 ALDH1A1 839/4885HPGD 377/4885MEN1 3804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.